Increases in serum IL-2 may be a pathway which attempts to compensate for the loss of protein kinase phosphorylation and TRPM3-dependent cell dysfunction in ME/CFS patients. The gene discussed is WEE1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.